We sought to evaluate the relationships among circulating levels of an endogenous ouabain-like factor (EO) and systemic hemodynamics and left ventricular (LV) geometry in patients with recently diagnosed essential hypertension. We selected 92 never-treated patients with essential hypertension. Blood samples were drawn for estimation of plasma EO (radioimmunoassay) and subjects underwent echocardiographic examination to evaluate LV end-systolic and end-diastolic wall thickness and internal dimensions. LV volumes, stroke volume, cardiac output, total peripheral resistance, LV mass, and relative wall thickness were calculated, and all except the last parameter were indexed by body surface area. LV mass also was indexed by height 2.7 . On the basis of the values of LV mass index (body surface area or height 2.7 ) and relative wall thickness, subjects were divided into groups with either normal geometry, concentric remodeling, concentric hypertrophy, or eccentric nondilated hypertrophy. In the study population as a whole, circulating EO levels were significantly and directly correlated with mean blood pressure (r ϭ 0.21, P ϭ .048), relative wall thickness (r ϭ 0.34, P ϭ .001), and total peripheral resistance index (r ϭ 0.37, P ϭ .0003). Plasma EO also was significantly and inversely correlated with LV end-diastolic volume index (r ϭ Ϫ0.32, P ϭ .002), stroke index (r ϭ Ϫ0.34, P ϭ .0009), and cardiac index (r ϭ Ϫ0.35, P ϭ .0007). In multiple regression analysis, plasma EO was an independent correlate of total peripheral resistance index, cardiac index, and relative wall thickness. Regardless of the indexation method used for LV mass, plasma EO was higher in patients with concentric remodeling than in those with either normal geometry or concentric hypertrophy. Plasma EO tended to be higher (indexation by body surface area) or was significantly higher (indexation by height 2.7 ) in subjects with concentric remodeling than in those with eccentric nondilated hypertrophy. Patients with concentric remodeling showed the highest total peripheral resistance index and the lowest cardiac index. Our data suggest that EO plays a role in regulating systemic hemodynamics and LV geometry in patients with essential hypertension.
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O
verwhelming evidence indicates the presence of specific endogenous inhibitors of Na,K-ATPase in the circulation and tissues of hypertensive animals and humans. [1] [2] [3] [4] [5] [6] These substances affect peripheral vascular resistance and may be linked with sodium homeostasis. [4] [5] [6] It has been reported that ouabain or a closely related isomer circulates in humans. 7, 8 Accumulating evidence suggests also that this endogenous ouabain (EO) is involved in the pathogenesis of some forms of essential hypertension. 9 -13 Among patients with early essential hypertension, various studies indicate that the hemodynamic pattern is not uniform.
14 Indeed, a high-cardiac output phase may not be a feature in all hypertensive subjects and hypertension may start with an increase in total peripheral resistance. Moreover, the high cardiac output phase, if present, usually disappears over some years.
14 The triggering mechanisms and the reasons that underlie the different hemodynamic patterns in hypertensive patients are not understood but probably reflect different mechanisms.
Left ventricular (LV) hypertrophy is a well-recognized response of the myocardium to sustained increases of blood pressure (BP). 15 However, the adaptation of the left ventricle to hypertension also appears to be complex. 16 Whereas many hypertensive patients exhibit normal LV geometry, others have concentric remodeling or concentric hypertrophy or eccentric hypertrophy. 16 Among hypertensive patients, those with concentric ventricular remodeling appear to have the lowest intravascular volume and the highest peripheral vascular resistance, whereas those with eccentric nondilated hypertrophy have the highest volume load and the lowest peripheral vascular resistance. 16 The heterogeneity of the hemodynamic and cardiac parameters, along with an earlier observation that elevated levels of EO affect a portion of patients with essential hypertension, 11 prompted us to consider possible interrelationships among these factors. Therefore, we investigated whether the circulating levels of EO are related to the hemodynamic pattern and LV geometry in recently diagnosed untreated patients with essential hypertension.
Methods

Subjects Studied
We studied 92 previously untreated patients with recently diagnosed hypertension (known duration, Ͻ18 months). Exclusion criteria for entry in the study were ischemic or valvular heart disease, congestive heart failure, cerebrovascular accidents, diabetes mellitus, chronic renal failure, known secondary hypertension, antihypertensive drug and digoxin use (present or past), and a limited echocardiographic acoustic window. The study was in accordance with the Second Declaration of Helsinki and was approved by the Institutional Committee on Human Research. All participating subjects gave written informed consent.
Office Blood Pressure Measurements
Clinical systolic and diastolic BP were recorded according to the standard technique. Clinical hypertension was defined as systolic BP Ն140 mm Hg or diastolic BP Ն90 mm Hg on repeat office visits.
Echocardiography
Echocardiograms were recorded with a Hewlett-Packard 77030A ultrasound imaging system equipped with a 2.5-or 3.5-MHz transducer. Two-dimension guided M-mode echocardiograms of the left ventricle were taken at the cordal level with the patient in the partial left lateral decubitus position, and three to five measurements were averaged. End-systolic and end-diastolic measurements of interventricular septal thickness, LV internal diameter, and posterior wall thickness were made according to the American Society of Echocardiography recommendations. 17 LV mass was calculated using the formula introduced by Devereux et al 18 based on necropsy validation studies. Individual values for LV mass were indexed by body surface area and LV hypertrophy was defined as LV mass/body surface area Ͼ125 g/m 2 in men 19 and Ͼ110 g/m 2 in women. 20 LV mass was also indexed by height 2.7 and LV hypertrophy 21 was also defined as LV mass/m 2.7 Ͼ51 g/m 2.7 in both genders. End-diastolic relative wall thickness (RWT) was calculated as the ratio of posterior wall thickness plus septal wall thickness to LV internal diameter. Patients with normal LV mass index and RWT Ͻ0.45 or Ͼ0.45 were considered to have normal LV geometry or concentric remodeling, respectively. 19 Those with increased LV mass index and RWT Ͻ0.45 or Ͼ0.45 were considered to have eccentric nondilated hypertrophy or concentric hypertrophy, respectively.
19 LV end-diastolic and end-systolic volumes were obtained by using the Teichholz formula, 22 which proved accurate in the absence of regional abnormalities of contraction. 23 Stroke volume was calculated as the difference between enddiastolic and end-systolic volumes. Ejection fraction was calculated as the ratio of stroke volume to LV end-diastolic volume. Individual values for end-diastolic and endsystolic volumes and stroke volume were indexed by body surface area (LV end-diastolic volume index, LV endsystolic volume index, and stroke index, respectively). Stroke index was multiplied by heart rate to obtain cardiac index. Total peripheral resistance index (TPRI) was assessed as [(mean arterial BP ϫ 80)/cardiac index]; mean BP was estimated as 1 ⁄3 pulse pressure plus diastolic pressure. BP was recorded at the time of echocardiography. The reproducibility of echocardiographic measurements in our laboratory has been previously reported. 24 
Laboratory Measurements
Blood samples for EO, aldosterone, renin activity, plasma Na ϩ and K ϩ , and creatinine determinations were drawn after a fasting period of 12 h. Venous blood for plasma renin activity and EO evaluation was collected into tubes containing 200 L of disodium EDTA, after 1 h of rest in the supine position. Samples for EO determination were centrifuged immediately at 3000 g for 15 min and the supernatant was collected and frozen at Ϫ20°C until assayed. Plasma renin activity and plasma aldosterone levels were measured using commercially available kits. Plasma EO was measured by a validated radioimmunoassay in which immunoreactivity correlates directly with inhibition of the sodium pump. 25 All hormone assays were performed with the investigator blinded to the patient status of the samples. Subjects also collected 24-h urine samples to evaluate Na ϩ and K ϩ excretion.
Statistical Analysis
Data are expressed as means Ϯ SD. Groups were compared by one-way ANOVA followed by Scheffé's test for multiple comparisons. 26 Relationships between continuous variables were evaluated by linear regression. Independence of association was assessed by multiple regression. 26 Analyses were made with the use of the StatView 4.5 package (Abacus Concepts, Inc., Berkeley, CA) im-plemented on an Apple Macintosh personal computer. Statistical significance was defined as P Ͻ .05.
Results
General Data
The primary characteristics of the entire study population are presented in Table 1 and the relationships of plasma EO levels to BP, cardiac structure, and hemodynamic data are reported in Table 2 .
The relationship between plasma EO and systolic and diastolic BP approached but did not attain statistical significance, whereas EO was significantly correlated with mean BP. Plasma EO was directly correlated with interventricular septal thickness, posterior wall thickness, RWT, and TPRI (Fig. 1) . Plasma EO inversely correlated with LV diastolic dimension, LV diastolic volume index, stroke index (Fig. 1) , and cardiac index. Multiple regression analysis, considering also plasma renin activity and aldosterone as independent variables, showed that EO explained a significant portion of the variance of TPRI and cardiac index independently (Table 3) . Using the same approach, EO was found to be an independent correlate of RWT (Table 3) .
Data by LV Geometry
The clinical characteristics, BP, and laboratory findings of the study population grouped according to LV geometry are reported in Table 4 . The gender distribution was not statistically different among the groups, although subjects with concentric hypertrophy were predominantly men.
FIG. 1.
Relationships among endogenous ouabain-like factor (EO) and total peripheral resistance index (TPRI) (top) and stroke index (bottom). EO is expressed as pmoles/per liter, TPRI as dynes ⅐ s ⅐ cm Ϫ5 ⅐ m 2 , and stroke index as milliliter per meter square. IVS ϭ interventricular septal; RWT ϭ relative wall thickness; other abbreviations as in Table 1 .
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Patients with concentric hypertrophy were older and had higher systolic BP than those with normal LV geometry. Subjects with concentric remodeling had higher diastolic BP than those with normal geometry. There was no significant difference among the groups concerning body surface area, heart rate, plasma renin activity, aldosterone, creatinine, plasma and urinary Na ϩ and K ϩ . Plasma renin activity and aldosterone were not obtained in 18 subjects. Plasma EO was significantly higher in patients with concentric remodeling than in those with normal geometry and concentric hypertrophy (Fig. 2) . Plasma EO also was higher in subjects with concentric remodeling than in those with eccentric hypertrophy, although the statistical significance was approached (P Ͻ .066) probably as a result of the relatively small number of patients (n ϭ 11) in the latter group.
Echocardiographic and hemodynamic data of the study population grouped according to LV geometry are shown in Table 5 . LV systolic function was normal and similar among the groups. Patients with concentric remodeling had the lowest LV diastolic volume, stroke and cardiac index, and the highest TPRI, whereas those with eccentric hypertrophy had the highest LV diastolic volume, stroke and cardiac index, and the lowest TPRI.
When LV mass was indexed by height 2.7 , one patient with normal geometry was reclassified as having eccentric nondilated LV hypertrophy, seven patients with concentric remodeling were reclassified as having concentric hypertrophy, and one patient with concentric hypertrophy was reclassified as having concentric remodeling. Thus, patient numbers in the groups with normal geometry, concentric remodeling, concentric hypertrophy, and eccentric hyper- Abbreviation as in Tables 1 and 2 . * P Ͻ .05 v normal geometry.
trophy were 28, 28, 24, and 12, respectively; LV mass/ m 2.7 values in the same groups were 40.3 Ϯ 5, 42.2 Ϯ 5, 57.8 Ϯ 4.7, and 55.8 Ϯ 3.6 g/m 2.7 , respectively. Following this reclassification, the measured variables showed either a similar trend among the groups or small differences emerged. The primary new finding of relevance following reclassification was that plasma EO levels were significantly higher in patients with concentric ventricular remodeling than in those with either normal geometry, concentric hypertrophy, or eccentric hypertrophy (489 Ϯ 211 v 285 Ϯ 114, 348 Ϯ 180 and 313 Ϯ 134 pmol/L, respectively; P Ͻ .05).
Discussion
Main Findings
The main findings of the present investigation are as follows. First, in the study population, the circulating levels of EO were directly related to mean BP and TPRI and inversely related to cardiac index. Second, the highest circulating levels of EO were found in subjects with the highest vascular resistance and the lowest cardiac index. In these patients, LV concentric remodeling was most apparent probably as a result of the opposite associations (direct or indirect) of EO with LV wall thickness and volume. Whether this aspect regards a specific group of hypertensive patients or represents an intermediate phase of the pathophysiologic changes of all hypertensive patients is unclear. Indeed, at present it is unknown whether LV concentric remodeling is a specific pattern that remains unchanged during time or is preceded or followed by other LV geometric patterns.
Comparison With Published Data
Volume expansion and an increase in total body sodium were thought to be the primary stimuli for the release of an Na,K-ATPase inhibitor involved in the onset of low-renin hypertension. 2, 4, 5, 10 The present results in humans provide no support for the association of plasma EO with volumerelated parameters in hypertensive patients. Although increased dietary salt has been reported to raise plasma EO levels in humans, 27 recent observations cast doubt on whether hypervolemia per se influences EO production. For example, EO levels were not correlated with plasma volume in patients with congestive heart failure. 28 In addition, acute saline infusion before and after sodium repletion did not modify circulating levels of EO in humans. 29 Further, Rossi et al 11 found a significant correlation between circulating EO and mean BP, and no
FIG. 2.
Endogenous ouabain-like factor (EO) levels in the study population according to left ventricular geometry. CH ϭ concentric hypertrophy; CR ϭ concentric remodeling; EH ϭ eccentric nondilated hypertrophy; NG ϭ normal geometry. Plasma EO values are pmoles per liter. association between EO levels and plasma renin activity, as observed also in the present study. These observations suggest that acute and possibly chronic plasma volume expansion is not the main stimulus for EO release. Collectively, the aforementioned data led experts to propose a new hypothesis 12 for the main events linking EO with the pathogenesis of hypertension. This scheme proposed that elevated EO primarily affects the central nervous system and activates central angiotensin II-dependent pathways that mediate sympathetic nerve activity.
Moreover, circulating EO and its interplay with tissue renin-angiotensin system and sympathetic nervous system might induce functional and structural cardiovascular changes by peripheral mechanisms. 12 In a recent study performed contemporaneously with the present one, Manunta et al 30 reported a positive correlation between EO and LV mass index and a weak positive correlation between EO and LV volume. In the present study, EO showed a positive correlation with LV wall thicknesses (possible direct and/or indirect association), a negative correlation with LV dimension and volume and no correlation with LV mass index. Notably, LV mass is influenced by both LV wall thickness and dimension. Thus, the difference between the two studies is explained by the different relations observed between EO and LV dimension or volume. This aspect may be related to different population characteristics. Indeed, in the study by Manunta et al, 30 hypertensive patients were younger, were predominantly men, and part of them had been previously treated. Moreover, although the known duration of hypertension does not differ between the two populations, it does not necessarily represent the real duration of hypertension. The prevalence of LV hypertrophy in this study was higher (31.5%) than in that by Manunta et al 30 (11.7%), who used also lower cutoff values than ours, suggesting that the real duration of hypertension in the present study would have been longer.
Conclusions
In this study, subjects with higher EO levels showed higher peripheral vascular resistance, low-normal cardiac index, and LV concentric remodeling. Our data suggest that EO plays a role in regulating systemic hemodynamics and LV geometry in patients with essential hypertension.
